James L Tyree
CIK 1324991 · Executive Vice President · last filed 2026-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ABT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNLX | Director | 96,483 | $2.42 | $233.5K | -$132.0K | 11 | 2026-06-18 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director | 12,550 | $23.50 | $294.9K | -$375.4K | 8 | 2024-03-15 |
| CCXI | Director | 0 | $10.66 | $0 | -$3.17M | 18 | 2022-10-24 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Director | — | — | — | $0 | 3 | 2018-05-10 |
| INVA | Director | 70,554 | $20.78 | $1.47M | -$8.5K | 3 | 2017-04-24 |
| Innoviva, Inc. (THRX) Delisted | Director | 33,182 | $4.06 | $134.7K | -$41.1K | 3 | 2015-06-04 |
| ABT | Executive Vice President | 134,575 | $104.89 | $14.12M | -$15.77M | 22 | 2009-03-03 |
Recent Filings · Page 7 of 8
73 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-05-16 | ABT | Mixed | +1,764 | -$62.6K | EDGAR |
| 2008-05-01 | ABT | Tax (F) | −539 | -$28.4K | EDGAR |
| 2008-03-06 | ABT | Sell (S) | −10,096 | -$535.5K | EDGAR |
| 2008-03-04 | ABT | Mixed | −17,321 | -$924.4K | EDGAR |
| 2008-02-27 | ABT | Mixed | +1,912 | -$49.5K | EDGAR |
| 2008-02-20 | ABT | Mixed | +26,813 | $1.49M | EDGAR |
| 2007-08-28 | ABT | Mixed | +10,749 | $444.0K | EDGAR |
| 2007-08-24 | ABT | Mixed | +3,307 | -$94.7K | EDGAR |
| 2007-07-03 | ABT | Tax (F) | −3,945 | -$211.3K | EDGAR |
| 2007-06-05 | ABT | Mixed | −13,333 | -$1.08M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.